![[Article Title]](https://media.americanpharmaceuticalreview.com/m/28/article/617584-134x100.jpg)
Detecting mycoplasma contamination with speed, sensitivity, and precision is essential for maintaining the quality and safety of cell therapy products. This application note outlines a protocol designed to facilitate the preparation and detection of mycoplasma DNA, meeting the sensitivity requirements specified in the European Pharmacopoeia chapter 2.6.7, 'Mycoplasmas,' with test sample volumes as low as 1 mL.
Download the application note to explore how the Applied Biosystems™ MycoSEQ™ Plus Mycoplasma Detection Kit integrates seamlessly into cell therapy workflows and supports low-volume sample testing.